Macroaxis gives Seattle performance score of 0 on a scale of 0 to 100. The firm has beta of 2.1 which indicates as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Seattle will likely underperform. Even though it is essential to pay attention to Seattle Genetics
current price movements, it is always good to be careful when utilizing equity historical returns. Macroaxis philosophy towards measuring future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators
. Seattle Genetics Inc exposes twenty-eight different technical indicators which can help you to evaluate its performance. Seattle Genetics
has expected return of -0.47%. Please be advised to validate Seattle Value At Risk
, and the relationship
between Jensen Alpha
to decide if Seattle Genetics
past performance will be repeated at some point in the near future.
Relative Risk vs. Return Landscape
If you would invest 3,573
in Seattle Genetics Inc on May 20, 2013
and sell it today you would lose (353.00)
from holding Seattle Genetics Inc or give up 9.88%
of portfolio value over 30
days. Seattle Genetics Inc is currenly does not generate positive expected returns and assumes 2.37% risk (volatility on return distribution) over the 30 days horizon. In different words, 29% of equities are less volatile than Seattle Genetics Inc and 99% of traded equity instruments are projected to make higher returns than the company over the 30 days investment horizon.
Daily Expected Return (%)
Given investment horizon of 30 days, Seattle Genetics Inc is expected to under-perform the market. In addition to that, the company is 2.82 times more volatile than its market benchmark. It trades about -0.2 of its total potential returns per unit of risk. The S&P 500 is currently generating roughly -0.05 per unit of volatility.
Seattle Operating Margin
Based on recorded statements Seattle Genetics Inc has Operating Margin of -26.44%. This is 7.62% lower than that of Healthcare sector, and 73.39% lower than that of Biotechnology
industry, The Operating Margin for all stocks is 599.47% higher than the company.
A good Operating Margin is required for a company to be able to pay for its fixed costs or pay out its debt which implies that the higher the margin, the better. This ratio is most effective in evaluating the earning potential of a company over time when comparing it against firm's competitors.
Seattle Return On Equity vs Return On Asset
Seattle Genetics Inc is rated below average
in return on equity category among related companies. It is rated below average
in return on asset category among related companies .